blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2306201

EP2306201 - Methods and compositions for assaying homocysteine [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  14.08.2015
Database last updated on 05.10.2024
Most recent event   Tooltip27.10.2017Lapse of the patent in a contracting state
New state(s): BE
published on 29.11.2017  [2017/48]
Applicant(s)For all designated states
GENERAL ATOMICS
3550 General Atomics Court
San Diego, CA 92121-1194 / US
[2011/14]
Inventor(s)01 / Yuan, Chong-Sheng
11404 Arabian Crest Rd.
San Diego, CA 92130 / US
02 / Datta, Abhijit
6426 La Garza Court
Carlsbad, CA 92009 / US
03 / Dou, Chao
5773 Concord Woods Way
San Diego, CA 92130 / US
 [2014/41]
Former [2011/20]01 / Yuan, Chong-Sheng
11404 Arabian Crest Rd.
San Diego, CA 92130 / US
02 / Datta, Abhijit
6426 La Garza Court
Carlsbad, CA 92009 / US
03 / Dou, Chao
5773 Concord Woods Way
San Diego, CA 92130 / US
Former [2011/14]01 / Yuan, Chong-Sheng
3590 Torrey View Court
San Diego, CA 92009 / US
02 / Datta, Abhijit
6426 La Garza Court
Carlsbad, CA 92009 / US
03 / Dou, Chao
5773 Concord Woods Way
San Diego, CA 92130 / US
Representative(s)Witte, Weller & Partner Patentanwälte mbB
Postfach 10 54 62
70047 Stuttgart / DE
[2014/41]
Former [2011/14]Witte, Weller & Partner
Postfach 10 54 62
70047 Stuttgart / DE
Application number, filing date10181606.409.07.2004
[2011/14]
Priority number, dateUS20030486865P10.07.2003         Original published format: US 486865 P
US2004080162315.03.2004         Original published format: US 801623
[2011/14]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP2306201
Date:06.04.2011
Language:EN
[2011/14]
Type: B1 Patent specification 
No.:EP2306201
Date:08.10.2014
Language:EN
[2014/41]
Search report(s)(Supplementary) European search report - dispatched on:EP26.01.2011
ClassificationIPC:C12Q1/34, C12Q1/48, G01N33/68
[2014/16]
CPC:
C12Q1/34 (EP,US); C12Q1/48 (EP,US); C12Q1/485 (EP,US);
G01N33/6815 (EP,US)
Former IPC [2011/14]G01N33/68
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IT,   LI,   LU,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2011/14]
TitleGerman:Verfahren und Zusammensetzung zum Bestimmen von Homocystein[2011/14]
English:Methods and compositions for assaying homocysteine[2011/14]
French:Procede et kit pour la detection d'homocysteine[2011/14]
Examination procedure06.10.2011Amendment by applicant (claims and/or description)
06.10.2011Examination requested  [2011/46]
08.08.2012Despatch of a communication from the examining division (Time limit: M04)
17.12.2012Reply to a communication from the examining division
30.04.2014Communication of intention to grant the patent
27.08.2014Fee for grant paid
27.08.2014Fee for publishing/printing paid
27.08.2014Receipt of the translation of the claim(s)
Parent application(s)   TooltipEP04777969.9  / EP1644741
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued (EP20040777969) is  27.06.2008
Opposition(s)09.07.2015No opposition filed within time limit [2015/38]
Fees paidRenewal fee
04.01.2011Renewal fee patent year 03
04.01.2011Renewal fee patent year 04
04.01.2011Renewal fee patent year 05
04.01.2011Renewal fee patent year 06
04.01.2011Renewal fee patent year 07
29.09.2011Renewal fee patent year 08
23.07.2012Renewal fee patent year 09
22.07.2013Renewal fee patent year 10
14.07.2014Renewal fee patent year 11
Penalty fee
Additional fee for renewal fee
31.07.201108   M06   Fee paid on   29.09.2011
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU09.07.2004
AT08.10.2014
BE08.10.2014
BG08.10.2014
CY08.10.2014
CZ08.10.2014
DK08.10.2014
EE08.10.2014
ES08.10.2014
FI08.10.2014
MC08.10.2014
NL08.10.2014
PL08.10.2014
RO08.10.2014
SE08.10.2014
SI08.10.2014
SK08.10.2014
TR08.10.2014
GR09.01.2015
PT09.02.2015
[2017/46]
Former [2017/39]HU09.07.2004
AT08.10.2014
BG08.10.2014
CY08.10.2014
CZ08.10.2014
DK08.10.2014
EE08.10.2014
ES08.10.2014
FI08.10.2014
MC08.10.2014
NL08.10.2014
PL08.10.2014
RO08.10.2014
SE08.10.2014
SI08.10.2014
SK08.10.2014
TR08.10.2014
GR09.01.2015
PT09.02.2015
Former [2016/13]AT08.10.2014
CY08.10.2014
CZ08.10.2014
DK08.10.2014
EE08.10.2014
ES08.10.2014
FI08.10.2014
MC08.10.2014
NL08.10.2014
PL08.10.2014
RO08.10.2014
SE08.10.2014
SI08.10.2014
SK08.10.2014
GR09.01.2015
PT09.02.2015
Former [2016/12]AT08.10.2014
CY08.10.2014
CZ08.10.2014
DK08.10.2014
EE08.10.2014
ES08.10.2014
FI08.10.2014
NL08.10.2014
PL08.10.2014
RO08.10.2014
SE08.10.2014
SI08.10.2014
SK08.10.2014
GR09.01.2015
PT09.02.2015
Former [2015/37]AT08.10.2014
CY08.10.2014
CZ08.10.2014
DK08.10.2014
EE08.10.2014
ES08.10.2014
FI08.10.2014
NL08.10.2014
PL08.10.2014
RO08.10.2014
SE08.10.2014
SK08.10.2014
GR09.01.2015
PT09.02.2015
Former [2015/36]AT08.10.2014
CY08.10.2014
CZ08.10.2014
DK08.10.2014
EE08.10.2014
ES08.10.2014
FI08.10.2014
NL08.10.2014
PL08.10.2014
RO08.10.2014
SE08.10.2014
GR09.01.2015
PT09.02.2015
Former [2015/35]AT08.10.2014
CY08.10.2014
DK08.10.2014
EE08.10.2014
ES08.10.2014
FI08.10.2014
NL08.10.2014
PL08.10.2014
SE08.10.2014
GR09.01.2015
PT09.02.2015
Former [2015/26]AT08.10.2014
CY08.10.2014
ES08.10.2014
FI08.10.2014
NL08.10.2014
PL08.10.2014
SE08.10.2014
GR09.01.2015
PT09.02.2015
Former [2015/25]AT08.10.2014
ES08.10.2014
FI08.10.2014
NL08.10.2014
PL08.10.2014
SE08.10.2014
GR09.01.2015
PT09.02.2015
Former [2015/24]ES08.10.2014
FI08.10.2014
NL08.10.2014
PL08.10.2014
SE08.10.2014
GR09.01.2015
PT09.02.2015
Former [2015/23]ES08.10.2014
FI08.10.2014
NL08.10.2014
PT09.02.2015
Former [2015/22]NL08.10.2014
PT09.02.2015
Former [2015/16]NL08.10.2014
Documents cited:Search[Y]WO0040973  (AXIS SHIELD ASA [NO], et al) [Y] 1-5 * page 9, paragraph 3; claims 1,13 *;
 [A]WO0077244  (UNIV VIRGINIA COMMONWEALTH [US]) [A] 1-5 * abstract *;
 [A]WO0102600  (GEN ATOMICS [US], et al) [A] 1-5 * abstract *;
 [Y]US2002123088  (MATSUYAMA NAOTO [JP], et al) [Y] 1-5 * page 6; claims 4-6,12-16 *;
 [A]WO03040694  (CATCH INC [US], et al) [A] 1-5* claims 5,13,71 *
by applicantUS5631127
 US5827645
 US5854023
 US5861294
 US5885767
 US5958717
 US5998191
 US6046017
 US6063581
 US6174696
 US6376210
 US6436658
 US2002119507
 WO03060478
 US6664073
 US6686172
    - FRANTZEN ET AL., "Enzyme Conversion Immunoassay for Determining Total Homocysteine in Plasma or Serum", CLINICAL CHEMISTRY, (1998), vol. 44, no. 2, pages 311 - 316
    - REFSUM ET AL., ANNU. REV. MEDICINE, (1998), vol. 49, pages 31 - 62
    - BAUAL ET AL., CLEVELAND CLINIC JOURNAL OF MEDICINE, (1997), vol. 64, pages 543 - 549
    - FOODY ET AL., CLINICIAN REVIEWS, (1998), vol. 8, pages 203 - 210
    - "Homocysteine: Selected aspects", PERRY T., Heritable disorders of amino acid metabolism., JOHN WILEY & SONS, (1974), pages 419 - 451
    - "The etiology of neural tube defects", SCOTT ET AL., Homocysteine metabolism: from basic science to clinical medicine, KLUWER ACADEMIC PUBLISHERS, (1995), pages 133 - 136
    - BOUSHEY ET AL., JAMA, (1995), vol. 274, pages 1049 - 1057
    - MOGHADASIAN ET AL., ARCH. INTERN. MED., (1997), vol. 157, pages 2299 - 2307
    - BOERS ET AL., J INHER. METAB. DIS., (1997), vol. 20, pages 301 - 306
    - UELAND ET AL., J LAB. CLIN. MED., (1989), vol. 114, pages 473 - 501
    - JACOBSEN ET AL., CLIN. CHEM., (1998), vol. 44, pages 2238 - 2239
    - DUCLOUX ET AL., NEPHROL. DIAL. TRANSPLANTL, (1998), vol. 13, pages 2890 - 2893
    - DIAZ-ARRASTIA ET AL., ARCH. NEUROL., (1998), vol. 55, pages 1407 - 1408
    - HORNBERGER ET AL., AMERICAN J OF PUBLIC HEALTH, (1998), vol. 88, pages 61 - 67
    - MANSOOR ET AL., ANAL. BIOCHEM., (1992), vol. 200, pages 218 - 229
    - STEIR ET AL., ARCH. INTERN. MED., (1998), vol. 158, pages 1301 - 1306
    - UELAND ET AL., CLIN. CHEM., (1993), vol. 39, pages 1764 - 1779 0
    - "Plasma homocysteine and cardiovascular disease", UELAND ET AL., Atherosclerotic Cardiovascular Disease, Hemostasis, and Endothelial Function, MARCEL DOKKER, (1992), pages 183 - 236
    - STEHOUWER ET AL., KIDNEY INTERNATIONAL, (1999), pages 55308 - 314
    - ARAKI ET AL., J. CHROMATOG., (1987), vol. 422, pages 43 - 52
    - STABLER ET AL., J. CLIN. INVEST., (1988), vol. 81, pages 466 - 474
    - MATSUYAMA ET AL., CLINICAL CHEMISTRY, (2001), vol. 47, pages 2155 - 2156
    - TAN ET AL., CLINICAL CHEMISTRY, (2003), vol. 49, pages 1029 - 1030
    - SHAPIRO; STANLEY K, METHODS ENZYMOL. 17 PT.B, SULFUR AMINO ACIDS, (1971), pages 400 - 405
    - SHAPIRO SK, BIOCHIM. BIOPHYS. ACTA, (1958), vol. 29, pages 405 - 9
    - THANBICHLER ET AL., J. BACTERIOL., (1999), vol. 181, no. 2, pages 662 - 5
    - SHAPIRO ET AL., J BIOL. CHEM., (1964), vol. 239, no. 5, pages 1551 - 6
    - THOMAS ET AL., JBIOL. CHEM., (2000), vol. 275, no. 52, pages 40718 - 24
    - COULTER-KARIS; HERSHFIELD, ANN. HUIN. GENET., (1989), vol. 53 2, pages 169 - 175
    - LAI ET AL., MOL. CELL. BIOL., (1997), vol. M5, pages 2413 - 24
    - CORNELL; RISCOE, BIOCHIM. BIOPHYS. ACTA, (1998), vol. 1396, no. 1, pages 8 - 14
    - SAKSELA; RAIVIO, BIOCHEM. J., (1996), vol. 315, no. 1, pages 235 - 9
    - MCNALLY ET AL., BIOCHEM. BIOPHYS. RES. COMMUN., (1997), vol. 231, pages 645 - 650
    - SINGH ET AL., EUR. J. BIOCHEM., (1996), vol. 241, pages 564 - 571
    - PEREZ-DE LA MORA ET AL., ANAL. BIOCHEM., (1989), vol. 180, no. 2, pages 248 - 52
    - GORE, INT. J. BIOCHEM., (1981), vol. 13, no. 8, pages 879 - 86
    - JOCELYN, METHODS OF ENZYMOLOGY, (1987), vol. 143, pages 243 - 256
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.